North America Intracranial Pressure Monitoring Devices Market Forecast to 2028 -Regional Analysis - by Offering (Products & Systems, Solutions & Platforms, and Services), Type (Invasive and Non-Invasive), Application (Traumatic Brain Injuries, Reye\'s Syn

North America Intracranial Pressure Monitoring Devices Market Forecast to 2028-Regional Analysis- by Offering (Products & Systems, Solutions & Platforms, and Services), Type (Invasive and Non-Invasive), Application (Traumatic Brain Injuries, Reye\'s Syndrome, Non-Traumatic Bleeds, Hydrocephalus, Space-Occupying Lesions, Cerebral Oedema, and Others), and End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others)

The intracranial pressure monitoring devices market in North America is expected to grow from US$ 715.80 million in 2023 to US$ 960.14 million by 2028. It is estimated to register a CAGR of 6.0% from 2023 to 2028.

Increasing Geriatric Population Fuels North America Intracranial Pressure Monitoring Devices Market

The incidence of neurological disorders has increased significantly among the geriatric population across the region. As per the Medical University of South Carolina, about 75% of strokes occur in people aged 65 years and above in the US. As per the World Health Organization, 20-30% of older people in the US suffered severe head injuries in 2021 as result of falls from standing height. As per the CDC, the number of older people aged 65 and above will be 73 million by 2030 in the US, of which 52 million may experience falls, and 12 million are likely to endure severe injuries due to falls. Similarly, the WHO has also estimated that the world’s population of people aged 60 years and older will double (2.1 billion) by 2050 from 1 billion in 2020. Thus, the growing geriatric population is likely to provide lucrative opportunities for the intracranial pressure (ICP) monitoring devices market during the forecast period.

North America Intracranial Pressure Monitoring Devices Market Overview

The North America intracranial pressure (ICP) monitoring devices market is segmented into the US, Canada, and Mexico. The US held the largest share of the North America intracranial pressure (ICP) monitoring devices market in 2021. This is attributed to increasing incidences of traumatic brain injuries (TBIs), rising geriatric population, growing investments in R&D by market players to evaluate new devices, and high per capita healthcare spending in the US.

North America Intracranial Pressure Monitoring Devices Market Revenue and Forecast to 2028 (US$ Million)

North America Intracranial Pressure Monitoring Devices Market Segmentation

The North America intracranial pressure monitoring devices market is segmented into offering, type, application, end user, and country.

Based on offering, the North America intracranial pressure monitoring devices market is segmented into product & systems, solutions & platform, and services. The products and systems segment held the largest share of the North America intracranial pressure monitoring devices market in 2023.

Based on type, the North America intracranial pressure monitoring devices market is segmented into invasive and non-invasive. The invasive segment held a larger share of the North America intracranial pressure monitoring devices market in 2023.

Based on application, the North America intracranial pressure monitoring devices market is segmented into traumatic brain injuries, Reye’s syndrome, non-traumatic bleeds, hydrocephalus, space-occupying lesions, cerebral oedema, and others. The traumatic brain injuries segment held the largest share of the North America intracranial pressure monitoring devices market in 2023.

Based on end user, the North America intracranial pressure monitoring devices market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment held the largest share of the North America intracranial pressure monitoring devices market in 2023.

Based on country, the North America intracranial pressure monitoring devices market is segmented into the US, Canada, and Mexico. The US dominated the North America intracranial pressure monitoring devices market in 2023.

Natus Medical Inc, RAUMEDIC AG, Sophysa SA, Integra LifeSciences Holdings Corp, Medtronic Plc, Braincare Desenvolvimento e Inovacao Tecnologica SA, NovaSignal Corp, Digitimer Ltd, and Longeviti Neuro Solutions LLC are among the leading companies operating in the intracranial pressure monitoring devices market in North America.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America intracranial pressure monitoring devices market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America intracranial pressure monitoring devices market, thereby allowing players across the value chain to develop effective long-term strategies
develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the intracranial pressure monitoring devices market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution